Payers may forgo PA restrictions in more collaborative model
Medicare & Reimbursement Advisor Weekly, November 20, 2009
Even if the products you support are orals for cardiovascular conditions, the following may be helpful to give you insight into a plan’s new-age thinking about utilization management. A flurry of single-source biologics with attractive side effect profiles is expected to enter the cancer care market without competition in the next few years. Requiring prior authorizations (PA) on the coming wave of expensive oncology-specific biologics is an option “but not Aetna’s preferred option as it might preclude payers from engaging in relationships with community oncologists, academic centers, hospitals, and cancer centers,” says Aetna’s Ira Klein, MD, medical director of oncology condition analysis. In lieu of a PA, Klein says payers could try a single-specialty arrangement with an oncology provider, or build a private label insurance product in which the plan acts as a third-party administrator.
PAs would close the door to these arrangements and stall recent collaboration among oncology groups and payers.
Editor’s note: E-mail bcote_18@hotmail.com to view the full article.
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Practice the six rights of medication administration
- Complications from immobility by body system
- Prevent dehydration with nursing interventions
- The consequences of an incomplete medical record
- Note similarities and differences between HCPCS, CPT® codes
- Know guidelines and subtle differences in code descriptions for laceration repairs
- Q&A: Primary, principal, and secondary diagnoses
- Skills of effective case managers
- Neurological checks for head injuries
- E-mailed
-
- Performing a SWOT analysis
- Unsuccessful v. aborted/discontinued procedures
- Q/A: Infusions in an interosseous line
- Plan ahead when creating a central billing office
- Nine ways to meet USP 797, get ready for your next survey
- Hospital Billing from A to Z: 3- and 1-day rules
- Don't bill 59025, 76818 separately without separate physician orders
- Documentation challenges for skin and dermatology coding
- Searched
